Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department: a Randomized Trial

NCT05304442 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT05304442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05304442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department: a Randomized Trial
Lead sponsor
Baylor College of Medicine
Phase
Phase 3
Overall status
Recruiting
Start date
September 15, 2022
Completion date
April 30, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron deficiency, uterine bleeding